Clinical, dermoscopic, histological and molecular analysis of BAP1‐inactivated melanocytic naevus/tumour in two familial cases of BAP1 syndrome
暂无分享,去创建一个
N. Soufir | A. Phan | J. Schmutz | A. de la Fouchardière | A. Bursztejn | S. Moawad | F. Granel-Brocard | M. Reigneau | F. Granel‐Brocard
[1] D. Pissaloux,et al. Atypical cutaneous melanocytic tumours arising in two patients with Li-Fraumeni syndrome. , 2017, Pathology.
[2] C. Shea,et al. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature , 2017, JAMA dermatology.
[3] M. Mihm,et al. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations. , 2015, Human pathology.
[4] Pierre Vabres,et al. Recommandations pour le diagnostic de prédisposition génétique au mélanome cutané et pour la prise en charge des personnes à risque , 2015 .
[5] L. Thomas,et al. [Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma]. , 2015, Annales de dermatologie et de venereologie.
[6] K. Busam,et al. Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome. , 2013, JAMA dermatology.
[7] A. von Deimling,et al. Combined BRAFV600E-positive Melanocytic Lesions With Large Epithelioid Cells Lacking BAP1 Expression and Conventional Nevomelanocytes , 2013, The American journal of surgical pathology.
[8] H. Pass,et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs , 2012, Journal of Translational Medicine.
[9] L. Cerroni,et al. A Distinct Subset of Atypical Spitz Tumors is Characterized by BRAF Mutation and Loss of BAP1 Expression , 2012, The American journal of surgical pathology.